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Abstract
Objective: To analyze the relationship between regular physical activity, as assessed by accelerometer and 7-day physical
activity recall (PAR), and plasma fibrinogen concentrations.
Methods: A cross-sectional study in a previously established cohort of healthy subjects was performed. This study analyzed
1284 subjects who were included in the EVIDENT study (mean age 55.0613.6 years; 60.90% women). Fibrinogen
concentrations were measured in blood plasma. Physical activity was assessed with a 7-day PAR (metabolic equivalents
(METs)/hour/week) and GT3X ActiGraph accelerometer (counts/minute) for 7 days.
Results: Physical exercise, which was evaluated with both an accelerometer (Median: 237.28 counts/minute) and 7-day PAR
(Median: 8 METs/hour/week). Physical activity was negatively correlated with plasma fibrinogen concentrations, which was
evaluated by counts/min (r =20.100; p,0.001) and METs/hour/week (r =20.162; p,0.001). In a multiple linear regression
analysis, fibrinogen concentrations of the subjects who performed more physical activity (third tertile of count/minute and
METs/hour/week) respect to subjects who performed less (first tertile), maintained statistical significance after adjustments
for age and others confounders (b=20.03; p = 0.046 and b=20.06; p,0.001, respectively).
Conclusions: Physical activity, as assessed by accelerometer and 7-day PAR, was negatively associated with plasma
fibrinogen concentrations. This relation is maintained in subjects who performed more exercise even after adjusting for age
and other confounders.
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Introduction
Participation in regular physical activity and/or aerobic exercise
training is associated with a decrease in all-cause, cardiovascular
and cancer mortality [1–3] and a reduced risk of fatal and non-
fatal coronary events in healthy individuals over a wide age range
[4]. A sedentary lifestyle is one of the major risk factors for
cardiovascular disease [5].
The anti-inflammatory effects of exercise are thought to be
mechanisms that explain the well-documented cardioprotective
effects of physical activity [6–8]. Regular physical activity is
associated with lower levels of inflammation markers over 10 years
of follow-up [9].
The meta-analysis by Kaptoge et al. [10], which included 33
studies with 883372 participants, concluded that plasma fibrino-
gen concentrations were associated with cardiovascular and non-
cardiovascular mortality, although its effects faded when adjusted
for other cardiovascular risk factors. They also found that long-
term increases in plasma fibrinogen concentrations of 1 g/litre
were associated with an approximate doubling of the risk for major
cardiovascular disease outcomes. Similarly, the addition of
fibrinogen concentrations to classic risk factors used in assessment
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scales for cardiovascular risk in people with an intermediate risk
can help predict additional events over a 10-year time period [11].
However, studies that have examined the relationship of
physical activity with fibrinogen have generally been conducted
by subjectively measuring physical activity through questionnaires
completed by the subjects. Objective assessments by an acceler-
ometer and the relationship of this measure with fibrinogen in the
general population have not yet been studied.
We hypothesized that physical activity can modify plasma
fibrinogen concentrations. Therefore, we aimed to analyze the
relationship between physical activity assessed objectively by an
accelerometer and self-reported physical activity through 7-day
physical activity recall (PARs) with plasma fibrinogen.
Methods
The 1284 subjects analyzed in this work derive from the
EVIDENT study (NCT01083082) [12].
Study population
Patients ranging 20–80 years of age were selected through
random sampling from general practitioner offices in 6 health
centers. The exclusion criteria were the following: known coronary
or cerebrovascular atherosclerotic disease, heart failure, moderate
or severe chronic obstructive pulmonary disease, walk-limiting
musculoskeletal disease, advanced respiratory, advanced respira-
tory, renal, or hepatic disease; severe mental disease; treated
oncological disease diagnosed in the past 5 years; terminally ill
patients; and pregnant women.
Of the 1553 subjects included in the EVIDENT study, 169 were
excluded because they did not have plasma fibrinogen concentra-
tions (115) or accelerometer (154) measurements. Therefore, this
study analyzed 1284 subjects in total. The sample size calculation
indicated that the number of patients included in the study (1284)
was sufficient to detect a difference of 20 mg/dl of fibrinogen
among tertiles of Counts/minute in a two-sided test, assuming a
common standard deviation (SD) of 89 mg/dl in fibrinogen with a
significance level of 5% and a power of 80%. The study was
approved by an independent ethics committee of Salamanca
University Hospital (Spain), and all participants gave written
informed consent according to the general recommendations of
the Declaration of Helsinki [13].
Anthropometric measurements
Body weight was determined on two occasions using a
homologated electronic scale (Seca770; Medical scale and
measurement systems, Birmingham, United Kingdom) following
due calibration (precision 60.1 kg), with the patient wearing light
clothing and shoeless. These readings were rounded to 100 g.
Height in turn was measured with a portable system (Seca 222;
Medical scale and measurement systems, Birmingham, United
Kingdom), recording the average of two readings, and with the
patient shoeless in the standing position. The values were rounded
to the closest centimeter. Body mass index (BMI) was calculated as
weight (kg) divided by height squared (m2). Waist circumference
was measured using a flexible graduated measuring tape with the
patient in the standing position without clothing. The upper
border of the iliac crests was located, and the tape was wrapped
around above this point, parallel to the floor, ensuring that it was
adjusted without compressing the skin. Body fat percentage was
measured using a body fat monitor previously validated (OM-
RON, model BF306; Omron Health Care, Kyoto, Japan) [14].
Laboratory determinations
Venous blood sampling was performed between 08:00 and
09:00 hours after the individuals fasted and abstained from
smoking and the consumption of alcohol and caffeinated
beverages for the previous 12 hours. Blood samples were collected
in the respective health centers, and were analyzed at the hospital
of the city participating in external quality assurance programs of
the Spanish Society of Clinical Chemistry and Molecular
Pathology. Fasting plasma glucose, creatinine, uric acid, serum
total cholesterol, HDL-cholesterol and triglyceride concentrations
were measured using standard enzymatic automated methods.
LDL cholesterol was estimated by the Friedewald equation when
the direct parameter was not available. Glycated haemoglobin was
measured with an immune-turbidimetric assay. High sensitive C-
reactive protein levels and fibrinogen concentrations were
determined by immunoturbidimetric assay. The blood concentra-
tion of insulin was determined by chemiluminescent microparticle
immunoassay. The insulin sensitivity was determined with the
Homeostasis Model Assessment Insulin Resistance (HOMA-IR)
index [15] through the following formula: fasting glucose (mmol/l)
6 fasting insulin (mU/ml)/22.5.
Office or clinical blood pressure
Office blood pressure measurement involves three measure-
ments of systolic blood pressure (SBP) and diastolic blood pressure
(DBP), using the average of the last two, with a validated
OMRON model M7 sphygmomanometer (Omron Health Care,
Kyoto, Japan), and following the recommendations of the
European Society of Hypertension [16]. The mean blood pressure
(MBP) was calculated by the following equation: MBP = [(2 *
DBP) + SBP]/3.
Physical activity
Physical activity was estimated by the 7-day physical activity
recall (PAR) and an accelerometer. The 7-day PAR is a general
measure of physical activity, which has been recognised as a valid
and reliable tool in recent years and is widely used in
epidemiological, clinical and behavioural change studies [17]. It
consists of a semi-structured interview (10–15 minutes) in which
participants provide an estimate of the number of hours dedicated
to physical or occupational activities that required at least a
moderate effort over the previous 7 days. The categories collected
are the following: moderate, hard and very hard physical activity.
The amount of time dedicated to each activity is multiplied by the
mean metabolic equivalents (METs) of each category, as follows:
light activity = 1.5; moderate = 4; hard = 6; and very hard = 10.
The sum of the products of the hours dedicated to each activity
and its estimated mean energy expenditure provides an estimation
of the kilocalories per kilogram used per day (kcal/kg/d). The dose
of physical activity was estimated in METs/hour/week, and active
persons were considered as those doing at least 30 minutes of
moderate activity for five days a week or at least 20 minutes of
hard activity for 3 days a week. Persons not reaching this level of
physical activity were considered sedentary [18].
ActiGraph GT3X accelerometers (ActiGraph, Shalimar, FL,
USA) were used, which have been previously validated [19].
Subjects wore the accelerometer fastened with an elastic strap to
the right side of the waist for 7 consecutive days except for during
bathing and performing activities in water. The data were
recorded at 1-minute intervals. The total physical activity was
expressed in counts per minute. The intensity of the physical
activity (low, moderate or high) was determined according to the
cut-off points proposed by Freedson [20]. When evaluated the
accelerometer data, three segments of the day were defined:
Physical Exercise and Fibrinogen
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morning (8 am to 3 pm), afternoon (3 pm to 10 pm) and evening
(10 pm to 8 am).
Reliability between 7-day PAR and accelerometer data was
evaluated by correlation coefficient (CC) between METs/hour/
week and counts/minute (r = 0.397; p,0.001) and total energy
expenditure measured by both methods (r = 0.471 p,0.001) and
intraclass CC of total energy expenditure (r = 0.584 (95% CI:
0.493 to 0.660); p,0.001). Convergent validity was evaluated
through the correlation between both tools used to measure
physical activity with the body fat percentage, counts/min (r =
20.230; p,0.001) and METs/hour/week (r =20.286; p,0.001).
Table 1. Baseline characteristics of participants in EVIDENT
study.
Mean ± SD/Median (IQR)/
n (%)
Age (years) 55.0613.6
Gender n (%)
Male 502 (39.10)
Female 782 (60.90)
Smoking status n (%)
Never 613 (47.70)
Current 276 (21.50)
Past 395 (30.80)
Alcohol. (g/week) 10 (70-0)
Body mass index (kg/m2) 26.7 (24.0–29.5)
Waist circumference cm 93 (85.00–100.75)
Obesity n (%) 278 (21.70)
Abdominal Obesity n (%) 560 (43.80)
Body fat percentage (%) 34.8067.50
Waist/Height cm/cm 0.56 (0.52–0.61)
Body adiposity index 26.0 (22.2–30.2)
Office systolic blood pressure (mmHg) 124.7617.0
Office diastolic blood pressure (mmHg) 77.3610.6
Mean blood pressure (mmHg) 92.9611.5
Hypertension n (%) 357 (28.00)
Fasting glucose (mg/dL) 89 (82.50–98.00)
Glycated hemoglobin (%) 5.50 (5.30–5.80)
HOMA Index 1.52 (0.86–2.43)
Diabetes n (%) 96 (7.50)
Total cholesterol (mg/dL) 214.29638.44
Triglycerides (mg/dL) 96 (71.00–135.00)
HDL-cholesterol (mg/dL) 58.00 (48.75–69.00)
LDL-cholesterol (mg/dL) 133.15634.65
Dyslipidemia n (%) 384 (30.10)
Lipid lowering drugs n (%) 238 (18.50)
Creatinine. (mg/dL) 0.8 (0.70–0.90)
Haemoglobin (g/dL) 14.30 (13.50–15.30)
Fibrinogen (mg/dL) 366 (319.00–415.00)
Ln Fibrinogen (mg/dL) 5.9060.22
hs-CRP (mg/dL) 0.17 (0.09–0.34)
Uric Acid (mg/dL) 4.80 (3.90–5.90)
Values are means (standard deviations) for continuous data. Median
(interquartile range) for asymmetrically distributed continuous data and
number and proportion for categorical data.
Body adiposity index = (hip circumference in centimeters)/(height in meters)1.5
2 18); HDL: High Density Lipoprotein; LDL: low-density lipoprotein; hs-CRP:
high-sensitivity C-Reactive Protein.
doi:10.1371/journal.pone.0087954.t001
Table 2. Physical exercise assessment by accelerometer and
7-day PAR.
Accelerometer Median/n IQR/(%)
Counts/minute 237.28 177.93–306.68
Sedentary (minutes/day) 1057.12 1012.30–1119.79
Light (minutes/day) 327.79 275. 97–363.47
Moderate (minutes/day) 45.14 27.26–65.62
Hard and very hard (minutes/day) 0.00 0.00–0.45
Kilocalories/day (KCALS) 241.53 130.07–402.67
7- day PAR
METs/hour/week 8 0.00–25.41
Active/sedentary according 7-par day
Sedentary n (%) 879 68.20
Active n (%) 405 31.80
Values are medians and interquartile range(IQR) for asymmetrically distributed
continuous data and number and proportions for categorical data.
METs: metabolic equivalent. Active were considered as those doing at least 30
minutes of moderate activity, five days a week, or at least 20 minutes of hard
activity, 3 days a week.
doi:10.1371/journal.pone.0087954.t002
Table 3. Bivariate correlations of physical exercise (Counts/
minute and METS/hour/week) with biological and
anthropometric parameters.
Count/minute
METS/Hour/
week
Fibrinogen (mg/dL) 20.100** 20.162**
hs-CRP (mg/dL) 20.181* 20.179*
HOMA Index 20.137** 0.055
Creatinine (mg/dL) 0.007 0.162**
Albumin/creatinine index (mg/g) 20.045 20.049
Uric Acid (mg/dL) 20.026 0.106**
Glycated hemoglobin (%) 20.085** 0.023
Haemoglobin (mg/dL) 0.075** 0.084**
Total Cholesterol (mg/dL) 0.038 20.009
HDL-Cholesterol (mg/dL) 0.133** 0.019
LDL-Cholesterol (mg/dL) 0.044 20.015
Triglycerides (mg/dL) 20.173** 20.063*
Body mass index (kg/m2) 20.126** 20.081**
Body fat percentage (%) 20.230** 20.236**
Waist/Height cm/cm 20.161** 20.111**
Body adiposity index 20.173** 20.155**
Counts/minute by accelerometer; METS/hour/week by 7-Par/day; hs-CRP: high-
sensitivity C-reactive protein; HDL: high-density lipoprotein; LDL: low-density
lipoprotein; Body adiposity index = ((hip circumference)/((height)1.5) -18)).
P-values by Spearman correlation. * p,0.05 ** p,0.01.
doi:10.1371/journal.pone.0087954.t003
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Statistical analysis
The continuous variables were expressed as the mean 6
standard deviation for normally distributed continuous data,
medians (interquartile range) for asymmetrically distributed
continuous data and frequency distribution for categorical data.
Statistical normality was checked using the Kolmogorov–Smirnov
test.
A Spearman’s correlation and intra-class correlation coefficients
were used to analyze the relationship between asymmetrically
distributed continuous data.
For the comparison in fibrinogen values between different
groups (tertiles) according to its physical activity levels (counts/min
and METS/hour/week), the non parametric test (Kruskal Wallis)
and post hoc comparisons were used. We performed a multiple
linear regression analysis, considering the plasma fibrinogen
concentrations as dependent variable and physical activity as
independent variable. The plasma fibrinogen concentrations do
not follow a normal distribution and it has been subjected to log
transformation in order to estimate the regression model. Physical
activity has been analyzed by considering their distribution in
tertiles of counts/minute and METs/hours/week (1st tertile less
exercise and 3rd tertile the most exercise). We adjusted the models
in a second step for age and gender (male = 1/female = 0) and in
a third step for ln waist circumference, alcohol, total cholesterol,
lipid lowering drugs (yes = 1; no = 0) and mean blood pressure.
The data were analyzed using IBMH SPSSH v.20 software. A value
of p,0.05 was considered statistically significant.
Results
We studied 1284 subjects with a mean age of 55.0613.6 years,
of which 60.90% were female. Table 1 shows the demographic
and clinical characteristics of the study patients.
Table 2 shows the physical activity as measured by both an
accelerometer (counts/minute) and a 7-day PAR (METs/hour/
week).
Subjects performed more physical activity in the morning
(120.30 counts/min) than in other segments of the day (afternoon:
100.13 counts/min, evening: 16.85 counts/min).
Physical activity, as assessed by counts/minute and METs/
hour/week showed an inverse correlation with the plasma
fibrinogen concentrations (r =20.100; p,0.001 r =20.162; p,
0.001 respectively) and with all anthropometric parameters. The
correlation of physical activity with other biological parameters is
shown in Table 3. Time expended in heavy/very heavy physical
activity was inversely associated with the plasma fibrinogen
concentrations (r =20.116; p,0.01).
In a multiple linear regression analysis, which considered
fibrinogen as dependent variable (Table 4), and the counts/minute
tertiles as independent variable. Fibrinogen concentrations of the
subjects who performed more physical activity (third tertile)
respect to subjects who performed less (first tertile), maintained the
statistical significance in all three models, with the first model
unadjusted (b=20.06; p,0.001), the second model adjusted for
age and sex (b=20.04; p,0.001) and the third model adjusted for
age, sex, waist circumference, alcohol consumption, total choles-
Table 4. Multiple regression with plasma fibrinogen concentrations as dependent variable and physical activity as independent
variable.
Dependent Variable: Ln_Fibrinogen b 95% CI p Dependent Variable: Ln_Fibrinogen b 95% CI p
Model 1
Counts/minute (T1) METS/hours/week (T1)
Counts/minute (T2) 20.03 20.06 0.01 0.061 METS/hours/week (T2) 20.04 20.07 20.01 0.010
Counts/minute (T3) 20.06 20.08 20.02 ,0.001 METS/hours/week (T3) 20.08 20.11 20.05 ,0.001
Model 2
Counts/minute (T1) METS/hours/week (T1)
Counts/minute (T2) 20.02 20.05 0.02 0.189 METS/hours/week (T2) 20.03 20.07 20.01 0.028
Counts/minute (T3) 20.04 20.07 20.02 0.008 METS/hours/week (T3) 20.06 20.10 20.04 ,0.001
Sex 20.07 20.09 20.05 ,0.001 Sex 20.06 20.09 20.04 ,0.001
Age 0.10 0.06 0.15 ,0.001 Age 0.11 0.07 0.15 ,0.001
Model 3
Counts/minute (T1) METS/hours/week (T1)
Counts/minute (T2) 20.02 20.05 0.01 0.268 METS/hours/week (T2) 20.03 20.07 20.01 0.035
Counts/minute (T3) 20.03 20.06 20.01 0.046 METS/hours/week (T3) 20.06 20.09 20.03 ,0.001
Sex 20.08 20.11 20.06 ,0.001 Sex 20.08 20.11 20.05 ,0.001
Age 0.07 0.02 0.11 0.007 Age 0.07 0.02 0.12 0.004
Waist circumference. (cm) 0.20 0.10 0.31 0.001 Waist circumference 0.20 0.10 0.31 ,0.001
Alcohol (g/week) 0.00 0.00 0.00 0.115 Alcohol (g/week) 0.00 0.00 0.00 0.127
Total cholesterol. (mg/dL) 0.00 0.00 0.00 0.592 Total cholesterol. (mg/dL) 0.00 0.00 0.00 0.711
Lipid lowering drugs 0.02 20.02 0.05 0.333 Lipid lowering drugs 0.01 20.02 0.05 0.388
Mean blood pressure (mmHg) 0.01 0.00 0.01 0.209 Mean blood pressure (mmHg) 0.01 0.00 0.01 0.258
Dependent Variable: Ln_Fibrinogen
Independent Variables: Tertiles of Counts/minute. Tertiles of METS/hours/week.
Adjusted variables: Sex (1: male; 0: female); lnAge; Waist circumference. (cm); Alcohol (g/week); Total cholesterol. (mg/dL); Lipid lowering drugs (1:yes; 0:no); Mean blood
pressure (mmHg)
doi:10.1371/journal.pone.0087954.t004
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terol, hypolipidaemic drugs and mean arterial pressure (b=2
0.03; p = 0.046). Similarly with the METs/hour/week tertiles,
fibrinogen concentrations of the subjects who performed more
physical activity (third tertile) respect to subjects who performed
less (first tertile) maintained statistical significance in all three
models. In the first model unadjusted (b=20.08; p,0.001), the
second model adjusted for age and sex (b=20.06; p,0.001) and
the third model adjusted for age, sex, waist circumference, alcohol
consumption, total cholesterol, hypolipidaemic drugs and mean
arterial pressure (b=20.06; p,0.001).
Figure 1 shows the mean values of plasma fibrinogen
concentrations according to the counts/minute tertiles with
significant differences between the first and the third tertile (p,
0.001). The mean values of plasma fibrinogen concentrations
according to the METs/hour/week tertiles showed statistical
significance between the three tertiles (p,0.05, all).
Discussion
According to the results of this study, physical activity was
inversely associated with plasma fibrinogen concentrations, as
Figure 1. Plasma Fibrinogen concentrations according to the counts/minute and METs/hour/week tertiles. Count/minute tertiles (T1,
195; T2 195 to 278; T3.278). METS/hours/week tertiles (T1,1; T2 1 to 17.5; T3.17.5). P-values by Kruskal-Wallis test: a) counts/min p,0.001; b)
METS/hour/week p,0.05.
doi:10.1371/journal.pone.0087954.g001
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assessed by both an accelerometer and a 7-day PAR. These
associations were maintained in a multiple regression analysis after
adjustments for other confounding factors in subjects in the third
tertile of physical activity. This reinforces the importance of the
quantity and intensity of physical activity in reducing the
inflammatory cascade and of assessment factors such as fibrinogen
that are used in the clinic.
The fact that individuals performed more physical activity in the
morning than in other segments of the day can be useful in future
intervention designs to promote physical activity.
The assessment of physical activity by questionnaires has often
been questioned due to the influence of the individual’s subjective
perception. In this study, physical activity was assessed with two
tools for one week, a subjective one (the 7-day PAR), in which the
subject self-reported activity, and an objective one, which was
measured with an accelerometer. The inverse relationship
between physical activity and plasma fibrinogen concentrations
that was obtained in this study was similar using both tools. This
supports the validity of the physical activity data reported by the
subject in the 7-day PAR and is consistent with the data published
in other studies [6,21–23].
Observational studies show that the anti-inflammatory effects of
exercise are stable and that physical activity decreases fibrinogen
values [6,8,21], which coincides with the results of this work.
Similarly, the reduction of inflammatory markers by performing
physical exercise is as effective as that achieved with drug therapy,
suggesting that exercise may have broad anti-inflammatory effects
[1].
However, the study results published in the National Health and
Nutrition Examination Survey (NHANES) III study [21] suggest
that inflammatory markers are lower only in subjects who perform
vigorous activity (running and aerobic exercise), compared with
those who perform a less intense exercise, which supports the
potential importance of the exercise intensity in decreasing
inflammation. Studies evaluating the association of physical
activity and mortality found that after adjustments for confound-
ers, this association was only maintained in the groups that
performed a moderate intensity exercise HR = 0.54, (95% CI
= 0.41–0.72) [2]. In the Baltimore study, which was conducted in a
generally healthy population, the changes in total and high
intensity physical activity were independent predictors of all-cause
mortality only in men [24].
To summarise, these results indicate the importance of
considering both the intensity and the duration of physical activity
when examining the relationship between exercise and other
inflammatory factors and mortality. Similarly, Kirk A. et al. [25]
concluded according to the results of one intervention to increase
the physical activity in type 2 diabetics, that the physical activity
level was inversely associated with the plasma fibrinogen
concentrations (p = 0.03).
Limitations
The main limitation was the source of the data for the cross-
sectional study, which prevented us from establishing a temporal
relationship between the activity assessed with the accelerometer
or 7-day PAR and the plasma fibrinogen concentrations for one
week. In addition, we do not have physical activity monitoring
data at an individual level; therefore, we must assume that the
physical activity patterns remain fairly stable over time. However,
this is the first study that examined the relationship between
physical activity measured with two tools and plasma fibrinogen
concentrations in a sample of patients from a multicentre study
who were randomly selected so that they represented the patients
visiting the primary care clinics of different territories of the
Spanish state.
Conclusions
Physical activity, as assessed by accelerometer and 7-day PAR,
was inversely associated with plasma fibrinogen concentrations.
This relation was maintained in subjects who performed more
exercise even after adjusting for age and other confounders.
Further research prospective/intervention studies are required in
order to confirm the inverse association found between the
physical activity and plasma fibrinogen concentrations.
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